HCA

SEC source: 0001209191-17-032131 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP- Employer&Payer Engagement

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,496

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031415 · doc4.xml · derivative · entry 9

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,688

Underlying: Common Stock · 2,562 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-17-031415 · doc4.xml · derivative · entry 8

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-17-031415 · doc4.xml · derivative · entry 7

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,100

Underlying: Common Stock · 2,750 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-17-031415 · doc4.xml · derivative · entry 6

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,375

Underlying: Common Stock · 4,125 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.

SEC source: 0001209191-17-031415 · doc4.xml · nonDerivative · entry 4

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,637

SEC source: 0001209191-17-031415 · doc4.xml · nonDerivative · entry 3

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031415 · doc4.xml · nonDerivative · entry 2

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,851

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031415 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,351

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 8

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 361,205

F9 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.06 to $84.21, inclusive.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 7

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 359,450

F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.15 to $84.04, inclusive.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 8

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,205

F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $84.06 to $84.21, inclusive.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 7

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 359,450

F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.15 to $84.04, inclusive.

SEC source: 0001209191-17-030380 · doc4.xml · nonDerivative · entry 4

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240,152

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.18 to $83.36, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 6

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 287,600

F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.50 to $83.83, inclusive.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 5

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 262,179

F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.61 to $83.49, inclusive.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 4

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 188,989

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.64 to $82.60, inclusive.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 6

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,600

F6 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $83.50 to $83.83, inclusive.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 5

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,179

F5 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.61 to $83.49, inclusive.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 4

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,989

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $81.64 to $82.60, inclusive.

SEC source: 0001209191-17-030380 · doc4.xml · nonDerivative · entry 3

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 246,317

SEC source: 0001209191-17-030380 · doc4.xml · nonDerivative · entry 2

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 252,417

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.97 to $83.70, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-030313 · doc4.xml · nonDerivative · entry 1

HOLLIDAY CHARLES O JR · CIK 0001127289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,304

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030464 · doc4.xml · nonDerivative · entry 3

FRIST PATRICIA C · CIK 0001181963 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly by Thomas F. Frist Jr.

Disclosed balance after: 167,000

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.66 to $83.05, inclusive. The Reporting Person undertakes to provide HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3), (5), (6), (7) and (8) to this Form 4.

F4 · ownership.nature: The Reporting Person may be deemed to have indirect beneficial ownership in respect of shares of common stock of HCA Holdings, Inc. through an indirect pecuniary interest in such shares held by her husband, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030463 · doc4.xml · nonDerivative · entry 3

FRIST THOMAS F JR · CIK 0000900596 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,000

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $82.66 to $83.05, inclusive. The Reporting Person undertakes to provide HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (3), (4), (5), (6) and (7) to this Form 4.

SEC source: 0001209191-17-030380 · doc4.xml · nonDerivative · entry 1

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,252

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.08, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-17-030360 · doc4.xml · nonDerivative · entry 2

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,168

F3 · shares: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the 2018 annual shareholders' meeting of HCA Holdings, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Holdings, Inc.

F4 · ownership.direct: The Reporting Person directly owns 56 shares of common stock of HCA Holdings, Inc. The Reporting Person directly owns 1,065.745 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc. by virtue of his ownership in Hercules. The Reporting Person may also be deemed to have indirect beneficial ownership in respect of 4,128 shares of common stock of HCA Holdings, Inc. and 78,155.825 units of Hercules, through an indirect pecuniary interest in such shares and units held by his children and his wife, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001209191-17-030356 · doc4.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,112

F3 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the 2018 annual shareholders' meeting of HCA Holdings, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Holdings, Inc.

SEC source: 0001209191-17-030329 · doc4.xml · nonDerivative · entry 1

ROWE JOHN W · CIK 0001181744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,188

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030327 · doc4.xml · nonDerivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,901

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030325 · doc4.xml · nonDerivative · entry 1

MEYERS GEOFFREY G · CIK 0001197285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,953

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030321 · doc4.xml · nonDerivative · entry 1

Light Jay O · CIK 0001445077 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,953

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-17-030316 · doc4.xml · nonDerivative · entry 1

LAMONT ANN H · CIK 0001199270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,871

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030311 · doc4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,832

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-17-030309 · doc4.xml · nonDerivative · entry 1

Dennis Robert J · CIK 0001295441 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,914

F1 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the Issuer's 2018 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-17-027458 · doc4.xml · derivative · entry 3

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,450

Underlying: Common Stock · 2,150 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The option vested in two equal annual installments beginning on November 2, 2014.

SEC source: 0001209191-17-027458 · doc4.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,103.5974

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-027458 · doc4.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · President-Physician Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,253.5974

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 14

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F9 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 13

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,125 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 12

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,375 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F8 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 11

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,375 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 10

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,184 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F6 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 9

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 8

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,505 shares

Expires 2019-08-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.

F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 6

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,357.0531

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 5

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,313.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 4

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,813.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 3

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,688.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 2

Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,938.0531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.